Surgery Partners, Inc. (NASDAQ:SGRY) Stock Position Trimmed by US Bancorp DE

US Bancorp DE lowered its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 15.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,678 shares of the company’s stock after selling 506 shares during the quarter. US Bancorp DE’s holdings in Surgery Partners were worth $86,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in SGRY. ProShare Advisors LLC raised its holdings in Surgery Partners by 7.8% during the 1st quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock worth $405,000 after buying an additional 986 shares during the period. Vanguard Group Inc. increased its stake in shares of Surgery Partners by 0.8% in the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after purchasing an additional 61,400 shares during the period. EntryPoint Capital LLC grew its stake in shares of Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after acquiring an additional 4,607 shares during the last quarter. Magnetar Financial LLC lifted its stake in shares of Surgery Partners by 511.7% in the first quarter. Magnetar Financial LLC now owns 165,466 shares of the company’s stock valued at $4,936,000 after buying an additional 138,415 shares during the period. Finally, Bamco Inc. NY increased its position in shares of Surgery Partners by 100.0% during the first quarter. Bamco Inc. NY now owns 90,000 shares of the company’s stock valued at $2,685,000 after purchasing an additional 45,000 shares during the period.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SGRY. Citigroup cut their target price on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th. Cantor Fitzgerald reissued an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a report on Friday, October 4th. KeyCorp assumed coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating for the company. StockNews.com downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. Finally, UBS Group began coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 target price on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, Surgery Partners currently has an average rating of “Moderate Buy” and a consensus target price of $40.71.

Surgery Partners Trading Down 7.3 %

Shares of Surgery Partners stock opened at $22.95 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.69 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 12-month low of $22.25 and a 12-month high of $36.92. The company has a market cap of $2.92 billion, a price-to-earnings ratio of -47.81, a PEG ratio of 18.74 and a beta of 2.76. The company’s 50-day moving average price is $30.62 and its 200-day moving average price is $28.45.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company’s revenue was up 14.3% on a year-over-year basis. During the same period last year, the firm posted $0.15 EPS. On average, equities analysts expect that Surgery Partners, Inc. will post 0.83 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.